TNF and Behcet disease: In Japan, usage of infliximab (IFX), a chimeric mouse-human anti-TNF-α monoclonal antibody, has recently been covered by national health insurance in refractory cases of specific types of BD including entero-BD, neuro-BD, and vasculo-BD.